Femora
All Questions

Who should not take HRT?

Last reviewed July 6, 2026 by Dr. Sapna Jadhav, General Physician. Sources from ACOG, NHS, Mayo Clinic, CDC, NICE, NIH, Cochrane, and peer-reviewed journals.

Bottom lineSystemic HRT is generally avoided with current or past breast cancer, other hormone-sensitive cancers, unexplained vaginal bleeding, or active liver disease, while clot or stroke history, BRCA mutations, and migraine with aura call for specialist input rather than an automatic no - and vaginal estrogen plus non-hormonal options remain available to almost everyone.

Systemic HRT is generally avoided - or needs specialist input - with certain cancers, unexplained bleeding, clot or stroke history, or active liver disease.

Generally ruled out

Needs specialist advice, not an automatic no

Options if systemic HRT is off the table

Being unable to take systemic HRT does not mean living with untreated symptoms:

The deciding factor is an honest, complete medical history - which is exactly what your clinician needs from you at the first appointment.

This is general information, not medical advice. Read the full evidence review: the risks of HRT, and the alternatives: non-hormonal treatments.

Assess your symptoms first: menopause symptom score

Sources

  1. Hormone replacement therapy (HRT): Who can take it - NHS.
  2. Menopause: diagnosis and management (NG23) - National Institute for Health and Care Excellence (NICE).

Related questions

Free tools for this topic

Track your cycle with Femora

Get smart period predictions, symptom tracking, and personalized insights - free to download.

Download the App